Steris (STE) revenue and earnings history
Steris reported revenue of $5.94B for fiscal 2026 (year ended Mar 31, 2026), +8.7% on the year before, and net income of $782M.
Over 9 years, from fiscal 2017 to fiscal 2026, revenue grew at a compound rate of +9.5% a year.
Revenue and net income, 10 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026ended Mar 31, 2026 | $5.94B+8.7% | $1.1B | $782M | $1.34B | $369M | $972M | $61.7M | $236M | $242M | $440M | $1.81B | 10-K |
| 2025ended Mar 31, 2025 |
The latest quarter, insider trades and fund moves: Steris (STE) on OQRO.
Common questions
What was Steris's revenue in fiscal 2026?
$5.94B for the year ended Mar 31, 2026, as reported in its 10-K filed May 29, 2026. That is +8.7% on fiscal 2025 ($5.46B).
How fast has Steris's revenue grown?
From $2.61B in fiscal 2017 to $5.94B in fiscal 2026: a compound annual growth rate of +9.5% over 9 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Where these figures come from
The SEC’s companyfacts data: every figure Steris tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
